Eton Pharmaceuticals (ETON) Total Debt: 2020-2025
Historic Total Debt for Eton Pharmaceuticals (ETON) over the last 4 years, with Sep 2025 value amounting to $30.4 million.
- Eton Pharmaceuticals' Total Debt rose 636.17% to $30.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $69.3 million, marking a year-over-year increase of 261.40%. This contributed to the annual value of $29.8 million for FY2024, which is 454.11% up from last year.
- Per Eton Pharmaceuticals' latest filing, its Total Debt stood at $30.4 million for Q3 2025, which was up 0.63% from $30.2 million recorded in Q2 2025.
- Eton Pharmaceuticals' 5-year Total Debt high stood at $30.4 million for Q3 2025, and its period low was $364,000 during Q2 2022.
- Its 3-year average for Total Debt is $11.4 million, with a median of $4.8 million in 2024.
- In the last 5 years, Eton Pharmaceuticals' Total Debt plummeted by 51.40% in 2022 and then spiked by 636.17% in 2025.
- Quarterly analysis of 5 years shows Eton Pharmaceuticals' Total Debt stood at $1.4 million in 2021, then dropped by 27.15% to $1.0 million in 2022, then surged by 420.81% to $5.4 million in 2023, then soared by 454.11% to $29.8 million in 2024, then surged by 636.17% to $30.4 million in 2025.
- Its Total Debt was $30.4 million in Q3 2025, compared to $30.2 million in Q2 2025 and $29.8 million in Q4 2024.